.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Abstractvortrag

Integration of high-throughput in vitro drug screening and molecular profiling to characterize novel, molecularly targeted treatment approaches for glioblastoma

Appointment

Date: 29/10/2022

Time: 08:30 – 08:40

Talk time: 7 Min.

Discussion time: 3 Min.

Location / Stream:

Saal B

Session

Molekulare Diagnostik und Therapie III

Authors

Nan Qin (Düsseldorf), Johanna Louise Trübel (Düsseldorf), Thomas Beez (Düsseldorf), Nguyen Khoa Tran (Düsseldorf), Shu Zang (Düsseldorf), Jonas Krenz (Düsseldorf), David Pauck (Düsseldorf), Daniel Picard (Düsseldorf), Marc Remke (Düsseldorf), Ute Fischer (Düsseldorf), Guido Reifenberger (Düsseldorf), Gunnar Klau (Düsseldorf)